Name:
Ganaxolone (3-alpha-hydroxy-3-beta-methyl-5-alpha-pregnan-20-one)
Type:
Neurosteroid
AKA:
N/A
Ganaxolone (3-alpha-hydroxy-3-beta-methyl-5-alpha-pregnan-20-one) image
Synthetic substance, no natural derivative
IUPAC Logo
Ganaxolone (3-alpha-hydroxy-3-beta-methyl-5-alpha-pregnan-20-one) image
Ganaxolone, a synthetic neurosteroid, was developed in the 2010s for its anticonvulsant properties. It represents advancements in epilepsy treatment, providing a new option for managing seizures with a focus on efficacy and safety.
Synthetic Substances Image
Ganaxolone is a neuroactive steroid used to treat seizures and anxiety. It has sedative effects, reducing heart rate and causing drowsiness. Short-term use is effective for seizure and anxiety management, while long-term use is generally safe with minimal risk of dependency. Overdose risks are low, though excessive use may cause dizziness and impaired motor function. Safe use involves following prescribed dosages. Recent research supports its efficacy in treating seizures and anxiety, highlighting its safety profile.
N/A
Ganaxolone is a neurosteroid with anxiolytic and sedative effects. It may improve mood and reduce anxiety short-term, but long-term use could lead to dependence and cognitive effects. Recent research highlights its modulation of GABAergic systems and psychological impact.
N/A
Ganaxolone is a synthetic steroid with potential therapeutic uses in treating epilepsy and other neurological conditions. Its cultural significance lies in its role in advancing treatment options for epilepsy. Media coverage often highlights its potential benefits and research developments. Ganaxolone is used medicinally and is part of broader discussions about neurological treatments and drug development.
N/A